Kenvue Inc. (NYSE:KVUE) Shares Sold by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc lessened its position in Kenvue Inc. (NYSE:KVUE) by 3.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 17,861 shares of the company’s stock after selling 684 shares during the period. K.J. Harrison & Partners Inc’s holdings in Kenvue were worth $325,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the company. Manchester Capital Management LLC boosted its stake in shares of Kenvue by 80.8% in the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock valued at $25,000 after buying an additional 530 shares in the last quarter. Tradition Wealth Management LLC boosted its position in shares of Kenvue by 2.8% during the 4th quarter. Tradition Wealth Management LLC now owns 21,278 shares of the company’s stock worth $458,000 after purchasing an additional 575 shares in the last quarter. MV Capital Management Inc. grew its stake in shares of Kenvue by 71.2% during the 1st quarter. MV Capital Management Inc. now owns 1,544 shares of the company’s stock worth $33,000 after purchasing an additional 642 shares during the period. Royal Capital Wealth Management LLC increased its holdings in shares of Kenvue by 2.3% in the 4th quarter. Royal Capital Wealth Management LLC now owns 29,746 shares of the company’s stock valued at $640,000 after purchasing an additional 673 shares in the last quarter. Finally, Cove Private Wealth LLC lifted its stake in shares of Kenvue by 1.6% in the second quarter. Cove Private Wealth LLC now owns 44,539 shares of the company’s stock valued at $810,000 after purchasing an additional 700 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the topic of several recent analyst reports. UBS Group upped their target price on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Citigroup reduced their price objective on Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. HSBC boosted their target price on Kenvue from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Wednesday, May 8th. JPMorgan Chase & Co. boosted their price objective on shares of Kenvue from $22.00 to $24.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $24.00 target price on shares of Kenvue in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Kenvue has an average rating of “Hold” and an average target price of $22.64.

Kenvue Trading Down 0.9 %

NYSE KVUE traded down $0.20 during trading hours on Wednesday, hitting $21.72. 7,895,815 shares of the company’s stock were exchanged, compared to its average volume of 18,689,369. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.99. The firm has a market capitalization of $41.59 billion, a P/E ratio of 28.10, a price-to-earnings-growth ratio of 2.07 and a beta of 1.38. The business’s 50 day moving average is $19.34 and its 200-day moving average is $19.51. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $23.33.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. The firm had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. Kenvue’s revenue was down .3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.32 earnings per share. As a group, analysts anticipate that Kenvue Inc. will post 1.13 EPS for the current fiscal year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 28th. Shareholders of record on Wednesday, August 14th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.78%. The ex-dividend date is Wednesday, August 14th. This is an increase from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s payout ratio is 105.13%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.